Bispectral Index Throughout Esophageal Cancer Operation
Which Bispectral Index Score is Reliable Throughout Esophageal Cancer Operation?
Sponsor: Samsung Medical Center
Listed as NCT03397745, this NA trial focuses on Esophageal Cancer and remains completed. Sponsored by Samsung Medical Center, it has been updated 9 times since 2018, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Oct 2018 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
▶ Show 4 earlier versions
-
Aug 2018 — Oct 2018 [monthly]
Recruiting NA
-
Jun 2018 — Aug 2018 [monthly]
Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2018 — Mar 2018 [monthly]
Not Yet Recruiting NA
First recorded
Jan 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Samsung Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .